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surgery, but systolic function is preserved. Strain rate imaging combined with tissue Dop- 
pler imaging may be a feasible method to evaluate regional systolic left ventricular func- 
tion with apparently abnormal wall motion. 
1140-50 Atorvastatin Improves Myocardial Contractility in 
Moderately Hypercholesterolemic Patients as Assessed 
by Tissue Doppler Imaging During Dobutamine Stress 
Echocardiography 
Manolis Bountioukos, Don Poldermans, Jeroen J. Bax. Vinoria Rizzello, Eleni C. 
Vourvouri. Arend F. Schinkel, Miklos D. Kertai, Jos R. Aoelandt, Thoraxcenter, Erasmus 
MC, Ronerdam, The Netherlands 
Background: Statins have shown to exert a beneficial effect on cardiovascular system, 
via a number of “pleiotropic actions”. Reversal of endothelial dysfunction is evidently one 
of them. Our aim was to determine the effect of atorvastatm on myocardial function, 
using pulsed-wave tissue Doppler imaging (pw TDI). 
Methods: Twenty patients (age 57+11 years) with moderate hypercholesterolemia and 
peripheral arterial disease, without known coronary artery disease, were enrolled on ator- 
vastatin. All patients underwent pw TDI before the initiation of atolvastatin therapy (IOmg 
daily) and 6 months later. TDI was performed using a six-segment model. Myocardial 
systolic ejection velocity (V,), and early (V*) and’late (Vd diastolic velocities were mea- 
sured at rest and during low dose dobutamine infuslon (LDDI). No changes in msdlcal 
therapy and no major cardiac events occurred during the follow up. 
Results: Wall motion score index had no significant changes. while left ventricular ejec- 
tlon fraction at LDDI increased significantly at 6 months. The changes in myocardial TDI- 
velocities at rest and during LDDI are shown in Table. 
Table 
Before After P 
atorvastatin 6 months value 
V, (rest) 7.36 6.40 <O.OOl 
V, (low dose) 10.36 11.59 <O.ool 
V, (rest) 9.00 9.30 0.492 
V, (low dose) 10.26 10.38 0.602 
V, (rest) 9.36 10.35 0.009 
V, (low dose) 10.96 12.11 0.007 
V,/V, (rest) 0.96 0.90 0.109 
&IV, (low dose) 0.96 0.67 0.107 
V, , V,. and V, are expressed in cm/s 
P values < 0.05 were considered significant 
Conclusion : Myocardial y at rest and at low dose dobutamine infusion increased 
significantly in patients with moderate hypercholesterolemia and peripheral arterial 
disease, after treatment with atorvastatin. This might be the result of statin-induced 
normalization of dysfunctional coronary endothelium. 
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1141-31 Angiotensin Converting Enzyme Inhibitors Stabilize Lefl 
Ventricular Remodeling in Chronic Aortic Regurgitation 
Despite Abnormal Resting Mechanics 
Victor A. Ferrari, Susan Matuleviaus. Leon Axel, Craig H. Scott, Ewa Ksiezycka, Kevin 
Duny, Martin G. St. John Sunon, University of Pennsylvania, Philadelphia, PA 
Background: Prior studies have demonstrated impaired intramural function despite pre- 
selved global LV function in eccentric hypertrophy. We studied whether abnormalities in 
resting intramural mechanics in 14 patients (mean age 44) with eccentric LVH due to iso- 
lated asymptomatic moderate AR would return toward normal with acute afterload reduc- 
tion (ALR) aner nitroprusside (NP), and be sustained with chronic ALR using ACE 
inhibitors (ACEIs). Methods: We used tagged MRI to study global and regional LV sys- 
tolic function before and after acute ALR, using NP to reduce systolic blood pressure by 
lo-20 mmHg without changing heart rate (mean dose 0.6 mg/kg/min), and after ACEls 
for 3.5 years. We measured LV volumes (LVEDV and LVESV), mass, and EF. A 2-D 
homogeneous strain analysis measured the principal orihogonal strains El (greatest 
systolic elongation) and E2 (greatest systolic shortening). Symptoms were assessed at 
Baseline (B) and at 3.5 years. Results: Resting El was normal (Table), increased after 
NP, and remained normal at 3.5 years. E2 was reduced at B, and did not increase with 
acute or chronic ALR. LVEDV, LVESV, mass, and LVEF were unchanged, as were 
symptoms. Conclusions: In eccentric hyperirophy due to chronic AR, systolic lengthening 
(El) improved witfi acute ALR, and was maintained with chronic ALR, however, systolic 
shortening (E2) remained abnormal. Failure to augment E2 with acute and chronic ALR 
did not predict progressive adverse ventricular remodeling or development of symptoms 
long-term. 
El 
E2 
Baseline 
Pre-NP 
0.23+/s0.02 
-0.16+/-0.02 
JACC March 
3.5 yr follow-up 
Post-NP 
0.30+/-0.01’ 0.26+/e0.02 
-0.17+/-0.03 -0.17+/-0.01 
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1141-32 Gadolinium Enhanced Cardiovascular Magnetic 
Resonance Differentiates Anderson-Fabry Disease 
From Hypertrophic Cardiomyopathy 
JamesC. Moon, Bhavesh Sachdev, Andrew G. Elkington, William J. McKenna, Dudley .I. 
Pennell. Perry M. Elliott, Royal Brompton Hospital, London, United Kingdom, St. 
George’s Hospital, London, United Kingdom 
Background: Patients with Hypertrophic Cardiomyopathy (HCM) have areas of myocar- 
dial hyperenhancement on gadolinium enhanced Cardiovascular Magnetic Resonance 
(CMR). The cardiac manifestations of Anderson-Fabry disease (AFD) may mimic HCM. 
AFD is potentially treatable with enzyme replacement therapy and thus diagnosis is 
important. We hypothesised that gadolinium-DTPA CMR would differentiate HCM from 
AFD. 
Methods: Fineen male patients (mean 44 * 12 years) and 7 female heterozygotes 
(mebn 46 f 12 years) with AFD were compared to 40 patients with familial HCM (28 
male. mean 49 * 17 years). Cine and late gadolinium CMR was performed. 
Results: Eight male AFD patients (53%) had myocardial hyperenhancement (mean 7.7 
* 6.1%, range 3.6-20.6%) of total myocardium. The extent of hyperenhancement related 
to LV mass index (r= 0.79, p=O.O004) but not ejection fraction or ventricular volumes. 
Hyperenhancemenl was found in 3 (433b)females. In 10 (91%) patients, hyperenhance- 
ment occurred in the mid-myocardial layer of the basal lateral wall (figure 1); 2 male 
patients with severe LVH and systolic Impairment had additional hyperenhancement in 
other myocardial segments. Hyperenhancement in the basal-lateral wall was not seen in 
the 40 patients with familial HCM. 
Conclusions: Individuals with AFD have a unique pattern of myocardial hyperenhance- 
ment that can differentiate them from familial HCM. The reason for this distribution is 
unknown. 
Figure 1: AFD (left) vs a typical pattern in HCM (right). 
1141-33 Myocardial Blood Flow in Patients With Dilated 
Cardiomyopathy: Quantitative Assessment With 
Velocity-Encoded Cine Magnetic Resonance Imaging of 
the Coronary Sinus 
Norberl Watzinaer, Gunnar K. Lund, Maythem Saeed, Gautham P. Reddy, Philip A. 
Araoz, Ming Yang. Alan B. Schwartz. Martin Bedigian, Charles B. Higgins, University of 
California, San Francisco, San Francisco, CA, Novartis Pharmaceuticals, East 
Hannover, NJ 
Background: Recent studies reported that microcirculatory dysfunction may play a role 
in the pathophysiology and may be of prognostic value in patients with idiopathic dilated 
cardiomyopathy (IDC). This study sought to determine the feasibility of magnetic reso- 
nance imaging (MRI) to evaluate coronary flow reserve in IDC patients and healthy sub- 
jects. 
Methods: A total of 19 subjects (12 healthy volunteers and 7 IDC patients) were studied 
using tine MRI to measure lefl ventricular mass and a velocity-encoded tine MRI tech- 
nique to measure coronary sinus flow at rest and after dipyridamole Induced hyperemia. 
Absolute values of total myocardial blood flow (MBF) were calculated from coronary 
sinus flow and len ventricular mass. 
Results At baseline, MBF was not significantly diierent in patients with IDC (0.48 * 0.07 
mlimitig) and healthy subjects (0.55 f 0.19 ml/min/g, p = 0.41). Aner dipyridamole 
administration, MBF in IDC patients increased to a level significantly less than that in nor- 
mal volunteers (1.05 * 0.35 mllminlg versus 1.99 * 1.05 ml/min/g, p < 0.05). Conse- 
quently, MBF reserve was impaired in patients with IDC (2.19 * 0.77) compared to that in 
healthy subjects (3.51 f 1.29, p < 0.05). A moderate correlation was found between MBF 
reserve and left ventricular ejection fraction (r = 0.48, p < 0.05). 
Conclusion: MBF reserve is reduced in patients with IDC indicating that coronary micro- 
circulatory flow is impaired. This new MRI approach allows noninvasive assessment of 
microcirculatory function in humans and may have the potential to study the en&s of 
pharmacological interventions on coronary microcirculation. 
